Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LNK754 is a farnesyltransferase inhibitor. It is used for the treatment of cancer and Alzheimer's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | LNK754 is a farnesyltransferase inhibitor. It is used for the treatment of cancer and Alzheimer's disease. |
In vivo | In a mouse model of PD, APP(SL), at 6 months of age for 3 months, LNK-754 (0.9 mg/kg) significantly decreases α-synuclein plaques . |
Synonyms | LNK754 |
Molecular Weight | 479.96 |
Formula | C29H22ClN3O2 |
CAS No. | 439153-64-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(Rac)-CP-609754 439153-64-7 Microbiology/Virology Influenza Virus LNK-754 (Rac) CP 609754 LNK 754 LNK754 CP609754 CP-609754 (Rac)CP609754 CP 609754 inhibitor inhibit